Guilin Sanjin Pharmaceutical Co., Ltd. (002275)
Market Closed
25 Jul, 06:57
XSHE XSHE Primary ¥
14. 98
-0.04
-0.27%
¥
8.83B Market Cap
- P/E Ratio
0.7% Div Yield
4,848,378 Volume
- Eps
¥ 15.02
Previous Close Day Range
14.96 15.25
Year Range
12.13 16.99
Want to track 002275 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
002275 closed yesterday lower at ¥14.98, a decrease of 0.27% from Thursday's close, completing a monthly increase of or ¥14.98. Over the past 12 months, 002275 stock gained .
002275 is not paying dividends to its shareholders.
The last earnings report, released on May 16, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.06%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XSHE (CNY).
002275 Chart
Guilin Sanjin Pharmaceutical Co., Ltd. Dividends
| 002275 1 month ago | Other | ¥0.35 Per Share |
| 002275 8 months ago | Other | ¥0.25 Per Share |
| 002275 29 May 2024 | Other | ¥0.3 Per Share |
| 002275 27 Nov 2023 | Other | ¥0.3 Per Share |
| 002275 31 May 2023 | Other | ¥0.4 Per Share |
Guilin Sanjin Pharmaceutical Co., Ltd. Earnings
| 16 May 2025 Date | | - Cons. EPS | - EPS |
| 29 Oct 2024 Date | | - Cons. EPS | 0.14 EPS |
| 16 May 2024 Date | | - Cons. EPS | 0.04 EPS |
| 25 Apr 2024 Date | | - Cons. EPS | - EPS |
| 4 Mar 2024 Date | | - Cons. EPS | - EPS |
| 002275 1 month ago | Other | ¥0.35 Per Share |
| 002275 8 months ago | Other | ¥0.25 Per Share |
| 002275 29 May 2024 | Other | ¥0.3 Per Share |
| 002275 27 Nov 2023 | Other | ¥0.3 Per Share |
| 002275 31 May 2023 | Other | ¥0.4 Per Share |
| 16 May 2025 Date | | - Cons. EPS | - EPS |
| 29 Oct 2024 Date | | - Cons. EPS | 0.14 EPS |
| 16 May 2024 Date | | - Cons. EPS | 0.04 EPS |
| 25 Apr 2024 Date | | - Cons. EPS | - EPS |
| 4 Mar 2024 Date | | - Cons. EPS | - EPS |
Guilin Sanjin Pharmaceutical Co., Ltd. (002275) FAQ
What is the stock price today?
The current price is ¥14.98.
On which exchange is it traded?
Guilin Sanjin Pharmaceutical Co., Ltd. is listed on XSHE.
What is its stock symbol?
The ticker symbol is 002275.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.7%.
What is its market cap?
As of today, the market cap is 8.83B.
Has Guilin Sanjin Pharmaceutical Co., Ltd. ever had a stock split?
No, there has never been a stock split.
Guilin Sanjin Pharmaceutical Co., Ltd. Profile
| Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Xun Zou CEO | XSHE Exchange | CNE100000DY9 ISIN |
| CN Country | 2,567 Employees | - Last Dividend | 21 Apr 2011 Last Split | 10 Jul 2009 IPO Date |
Overview
Guilin Sanjin Pharmaceutical Co., Ltd., founded in 1967 and based in Guilin, China, has made a significant mark in the realm of traditional Chinese and natural medicines. The company dedicates itself to the research, production, and sale of these medicines within China. It stands as a shining example of a firm that successfully bridges the gap between ancient Chinese medical wisdom and modern pharmaceutical practices. Operating as a subsidiary of Guilin SanJin Group Co.,Ltd., Guilin Sanjin Pharmaceutical has entrenched itself as a trusted name in the healthcare sector, underlining its commitment to improving health and well-being through its range of products.
Products and Services
- Guilin Watermelon Frost and Lozenge: This product is a testament to the company's ability to harness traditional Chinese medicine (TCM) wisdom for contemporary health solutions. Utilized primarily for its soothing effects on the throat, it represents a blend of natural ingredients known for their healing properties. The popularity of the watermelon frost and lozenge highlights Guilin Sanjin's expertise in creating products that cater to common health concerns with natural remedies.
- Sanjin Tablets: Another proud offering under their Chinese TCM brand, Sanjin Tablets are marketed to address various conditions, demonstrating the company’s innovation in traditional medicine. The focus on utilizing TCM principles to formulate these tablets underscores Guilin Sanjin’s commitment to providing holistic and natural approaches to health and wellness.
- Naomaitai Capsules: These capsules are part of Guilin Sanjin’s approach to cater to the modern needs with traditional insights. The Naomaitai Capsules are designed using TCM knowledge to support the body in specific areas, showcasing the company's dedication to merging traditional practices with contemporary health needs.
- TCM Preparations: Beyond these products, Guilin Sanjin Pharmaceutical Co., Ltd. also engages in the production of a variety of TCM preparations. These preparations are crafted following traditional recipes and methods, adjusted to meet modern safety and efficacy standards. The company’s TCM preparations span a wide range of uses, aiming to promote overall health and well-being through natural and time-tested solutions.
Contact Information
Address: No.1, Gold Star(Jinxing) Road, Guilin, China
Phone: 86 77 3584 3251
Website: https://www.sanjin.com.cn
2025 © Marketlog. All Rights Reserved.
